CYCNNasdaq United States
Market cap
$16.712 M
$3.57 +0.28%
Close of 7 Aug 2026
Revenue
$2.07M
#3427 by revenue
Earnings
-$3.53M
Loss-making
Shares outstanding
4,681,351
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Cyclerion Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.